首页 | 本学科首页   官方微博 | 高级检索  
检索        

PRAME在儿童急性白血病诊疗中的研究进展
引用本文:聂莹.PRAME在儿童急性白血病诊疗中的研究进展[J].国际儿科学杂志,2010,37(4).
作者姓名:聂莹
作者单位:第四军医大学西京医院小儿科,西安,710032
基金项目:陕西科学技术研究发展计划项目 
摘    要:黑色素瘤特异性抗原(preferentially expressed antigen of melanoma,PRAME)基因作为泛白血病标志可用于微小残留白血病检测,并对疗效、预后、危险度分级及复发预测具有一定意义.此外,PRAME作为肿瘤相关抗原,可被细胞毒性T细胞识别,是白血病免疫治疗的理想靶点,对PRAME基因启动子区CpG岛甲基化的深入研究有助于理解PRAME基因在白血病中的表达机制及与白血病发生之间的关系.

关 键 词:黑色素瘤特异性抗原  微小残留白血病  免疫治疗  甲基化

Development of PRAME in the diagnosis and treatment of children acute leukemia
NIE Ying.Development of PRAME in the diagnosis and treatment of children acute leukemia[J].International Journal of Pediatrics,2010,37(4).
Authors:NIE Ying
Abstract:The gene of preferentially expressed antigen of melanoma(PRAME) is a gene marker of leukemia,which can be used to monitor the minimal residual disease,and can make us to comprehend the curative effect,prognosis,the grade of risk and can predict relapse.In addition,PRAME as a human tumour antigen,can be recognized by autologous cytolytic T lymphocytes,is a ideal target of immunotherapy in leukemia,and investigate the methylation level of PRAME gene CpG island,which can help us comprehend the relation of the mechanism of PRAME and leukemia.
Keywords:PRAME  Minimal residual disease  Immunotherapy  Methylation
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号